Mycosis Fungoides News

Seattle Genetics Releases Interim Results From Phase II Trial Of ADCETRIS - RTT News



Xconomy
 
Seattle Genetics Releases Interim Results From Phase II Trial Of ADCETRIS 
RTT News
The company stated that the clinical trial had enrolled 17 CTCL patients with mycosis fungoides or Sezary syndrome. The primary endpoint of the trial is clinical response rate. Secondary endpoints include correlation of clinical response with CD30 ...
Millennium, Seattle Genetics commence Phase III CTCL trial Pharmaceutical Business Review
Seattle Genetics Announces Data from Investigator Trial of ADCETRIS? in ... EON: Enhanced Online News (press release)

all 11 news articles » 


Seattle Genetics Announces Data from Investigator Trial of ADCETRIS(TM) in ... - MarketWatch (press release)



Xconomy
 
Seattle Genetics Announces Data from Investigator Trial of ADCETRIS(TM) in ... 
MarketWatch (press release)
The trial enrolled CTCL patients with mycosis fungoides (MF) or Sezary syndrome. At the time of data analysis, 17 patients had been enrolled, including 16 with MF and one with Sezary syndrome. Patients had received a median of six prior therapies, ...
Seattle Genetics Reports First Quarter 2012 Financial Results SunHerald.com

all 24 news articles » 


Seattle Genetics Reports First Quarter 2012 Financial Results - MarketWatch (press release)



Xconomy
 
Seattle Genetics Reports First Quarter 2012 Financial Results 
MarketWatch (press release)
... with Millennium: The Takeda Oncology Company, initiated an international phase III clinical trial of ADCETRIS for relapsed cutaneous T-cell lymphomas (CTCL), including primary cutaneous anaplastic large cell lymphoma and mycosis fungoides.
Millennium and Seattle Genetics Initiate Global Phase 3 Trial of ADCETRIS in ... PharmaLive.com (press release)

all 26 news articles » 


"SEND?KA UZMANI ?SMET ASLAN'A ÖZGÜRLÜK" KAMPANYASI BA?LATILDI - Haber X



Haber X
 
"SEND?KA UZMANI ?SMET ASLAN'A ÖZGÜRLÜK" KAMPANYASI BA?LATILDI 
Haber X
Kampanya metninde, ?smet Aslan'?n, cilt kanserinin bir türü olan Mycosis Fungoides (MF) hastas? oldu?u ve düzenli kontrollere gitmesi gerekti?i ifade edilirken, cezaevi ko?ullar?n?n ?smet Aslan'?n sa?l??? için ciddi bir tehdit olu?turdu?una da dikkat ...

 


ÇAR?AMBA GÜNDEM? - Haber X



Haber X
 
ÇAR?AMBA GÜNDEM? 
Haber X
Kampanya metninde, ?smet Aslan'?n, cilt kanserinin bir türü olan Mycosis Fungoides (MF) hastas? oldu?u ve düzenli kontrollere gitmesi gerekti?i ifade edilirken, cezaevi ko?ullar?n?n ?smet Aslan'?n sa?l??? için ciddi bir tehdit olu?turdu?una da dikkat ...

and more »